Association of Cognitive Impairment in Patients on 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase Inhibitors

BACKGROUND: Atherosclerotic cardiovascular diseases are the leading cause of death in the United States. A reduction in cholesterol with 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitors (statin) significantly reduces mortality and morbidity. Statins may be associated with cognitive impairment or...

Descripción completa

Detalles Bibliográficos
Autores principales: Roy, Satyajeet, Weinstock, Joshua Louis, Ishino, Allyse Sachiko, Benites, Jefferson Felix, Pop, Samantha Rachel, Perez, Christopher David, Gumbs, Edvard Adrian, Rosenbaum, Jennifer Ann, Roccato, Mary Kate, Shah, Hely, Contino, Gabriela, Hunter, Krystal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458663/
https://www.ncbi.nlm.nih.gov/pubmed/28611866
http://dx.doi.org/10.14740/jocmr3066w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458663/
https://www.ncbi.nlm.nih.gov/pubmed/28611866
http://dx.doi.org/10.14740/jocmr3066w

Ejemplares similares